Tower Research Capital (TRC)’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,939
Closed -$3.77K 6125
2024
Q1
$3.77K Sell
19,939
-30,632
-61% -$6.96K ﹤0.01% 4799
2023
Q4
$8.24K Buy
50,571
+15,449
+44% +$5.13K ﹤0.01% 4529
2023
Q3
$15.5K Buy
35,122
+2
+0% +$1 ﹤0.01% 3609
2023
Q2
$13K Buy
35,120
+24,339
+226% +$20.8K ﹤0.01% 3818
2023
Q1
$20K Buy
10,781
+6,999
+185% +$15.2K ﹤0.01% 3462
2022
Q4
$8K Buy
3,782
+1,056
+39% +$3.34K ﹤0.01% 4493
2022
Q3
$8K Sell
2,726
-17,355
-86% -$61.5K ﹤0.01% 4837
2022
Q2
$64K Buy
20,081
+7,892
+65% +$42.8K ﹤0.01% 2665
2022
Q1
$79K Buy
12,189
+9,165
+303% +$82.9K ﹤0.01% 2382
2021
Q4
$41K Buy
3,024
+2,995
+10,328% +$32.9K ﹤0.01% 2929
2021
Q3
$0 Buy
+29
New +$457 ﹤0.01% 6298

Other funds holding HLTH

Tower Research Capital (TRC)'s HLTH Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 19,939 shares — an estimated $3.77K sold.

Tower Research Capital (TRC) first reported a position in HLTH in Q3 2021 and held it in 11 quarters. The position peaked at $79K in Q1 2022. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Tower Research Capital (TRC) reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 19,939 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $3.77K.
  • Tower Research Capital (TRC) first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s Cue Health Inc. Common Stock position peaked at $79K in Q1 2022.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.